MAPK1 and nervous system disorder: With its role in learning and memory (Brambilla et al, 1997; Atkins et al, 1998), the ERK pathway has been intensely scrutinized as a therapeutic target for psychiatric and neurological disorders, largely via MEK inhibitors and in a few cases, genetic manipulations in the mouse (Fasano & Brambilla, 2011).